SOPHiA GENETICS
All Teams
SOPHiA GENETICS Leadership Team
We value diversity of background and mindset just as highly as experience and technical knowledge. Our executive team, board, and scientific personnel are a diverse mix of ages, genders, backgrounds, and ethnicities, with more than 80% holding PhDs with specialties from cell biology to computer science. It’s this diversity and originality, powered by a shared passion for delivering innovative healthcare solutions for all, that truly makes the SOPHiA GENETICS team unique.
Close
Employee Reviews
Dr. Jurgi Camblong, Ph.D., M.B.A., is a visionary entrepreneur who is pioneering the data-driven medicine movement around the world.
In 2011, he founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz and has successfully led the development of the company as CEO ever since.
Close
Ross Muken is a seasoned executive with more than 20 years of experience across life sciences, health technology, medical devices, and pharma services. Ross joined SOPHiA GENETICS in February 2021 as Chief Financial Officer, and in March 2023 was appointed Chief Financial Officer & Chief Operating Officer. In November 2024, Ross was appointed President.
Before joining SOPHiA GENETICS, he was CFO & COO of Click Therapeutics.
George Cardoza, M.B.A. joined the SOPHiA GENETICS leadership team as Chief Financial Officer in November 2024. Prior to joining SOPHiA GENETICS, he was the Chief Financial Officer and Head of Service Delivery for Biocartis. He joined Biocartis from Accuragen, where he was the Chief Executive Officer.
Manuela Da Silva Valente is a seasoned human resources executive with more than 20 years of experience working in international companies. Manuela joined SOPHiA GENETICS in January 2019 as our Chief People Officer from IQVIA (formerly Quintiles and IMS Health, Inc.), a human data science company, where she had a number of senior human resources roles, including from 2016 to 2018 the position of Global Senior Director of Human Resources. Prior to this, she worked for several years at Outcome Sciences, where she successfully established European operations and led the organization through an acquisition by Quintiles.
As Executive Vice President, Chief Legal & Regulatory Officer, Daan Van Well leads Legal Affairs, Regulatory Affairs, Quality Assurance, Risk & Compliance, and Information Security at SOPHiA GENETICS. With over 25 years of experience in top-tier private practice, in-house, and consulting roles, Daan brings extensive expertise in legal, governance, and compliance.
Zhenyu Xu, Ph. D., is a genome scientist with a background in molecular and computational biology. Zhenyu is among the most experienced bioinformaticians in clinical NGS data analysis worldwide. He joined SOPHiA GENETICS in January 2012 and is the leader of the technology team that developed the SOPHiA DDM™ platform – the universal technology for data-driven medicine.
Zhenyu has served as our Chief Scientific Officer since January 2021 and was previously our Chief Technology Officer since May 2014. Prior to that, Zhenyu was a postdoctoral fellow at the European Molecular Biology Laboratory.
Abhimanyu (Abhi) Verma, M.Sc., M.B.A., is a healthcare technology leader experienced in developing capabilities and leading multifunctional organizations to create and accelerate solutions that impact patients and joined SOPHiA GENETICS in February 2022. He has more than 17 years of life sciences industry experience centered on harnessing the intersection of people, science, technology, data & AI serving multiple therapeutic areas and functions across the pharma value chain.
Previously at Novartis, Abhi has proven to be a thought leader and execution champion at innovating and scaling data science and technology products, methodologies and approaches.
Kevin Puylaert is the Managing Director of EMEA at SOPHiA GENETICS. He joined the company in March 2016. With a passion for innovation and a drive to bring solutions to healthcare professionals around the world, Kevin leads the company’s efforts to accelerate the adoption of the SOPHiA DDM™ Platform in Europe, the Middle East and Africa.
With his industry expertise and entrepreneurial spirit, Kevin has been instrumental in the growth of SOPHiA GENETICS, driving the company’s global expansion through his expertise in developing and executing successful business strategies.
Recently posted jobs
Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Lead the development and validation of NGS-based IVD and CDx products, ensuring compliance with regulatory standards and efficient project delivery.
Artificial Intelligence • Big Data • Healthtech • Software • Biotech
The NGS Lab Technician will conduct sample preparation, perform NGS library preparation, operate sequencing instruments, and ensure compliance with lab standards.
Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Lead and coordinate Q4 close, year-end reporting, and external audit activities for a public-company environment. Act as primary liaison to external auditors, manage audit deliverables and open items, support SOX-related testing, review financial statements and consolidation workstreams, and ensure timely completion during a high-demand reporting period.
